These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29081054)

  • 1. Peptides and Drug Delivery.
    Ulapane KR; Kopec BM; Moral MEG; Siahaan TJ
    Adv Exp Med Biol; 2017; 1030():167-184. PubMed ID: 29081054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers.
    Laksitorini M; Prasasty VD; Kiptoo PK; Siahaan TJ
    Ther Deliv; 2014 Oct; 5(10):1143-63. PubMed ID: 25418271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible Opening of Intercellular Junctions of Intestinal Epithelial and Brain Endothelial Cells With Tight Junction Modulator Peptides.
    Bocsik A; Walter FR; Gyebrovszki A; Fülöp L; Blasig I; Dabrowski S; Ötvös F; Tóth A; Rákhely G; Veszelka S; Vastag M; Szabó-Révész P; Deli MA
    J Pharm Sci; 2016 Feb; 105(2):754-765. PubMed ID: 26869428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
    Kristensen M; Brodin B
    J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules.
    Greene C; Campbell M
    Tissue Barriers; 2016; 4(1):e1138017. PubMed ID: 27141420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to improve drug delivery across the blood-brain barrier.
    de Boer AG; Gaillard PJ
    Clin Pharmacokinet; 2007; 46(7):553-76. PubMed ID: 17596102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and function of the intercellular junctions: barrier of paracellular drug delivery.
    Zheng K; Trivedi M; Siahaan TJ
    Curr Pharm Des; 2006; 12(22):2813-24. PubMed ID: 16918412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability.
    Laksitorini MD; Kiptoo PK; On NH; Thliveris JA; Miller DW; Siahaan TJ
    J Pharm Sci; 2015 Mar; 104(3):1065-75. PubMed ID: 25640479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery to brain via the blood-brain barrier.
    Scherrmann JM
    Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.
    Alaofi A; On N; Kiptoo P; Williams TD; Miller DW; Siahaan TJ
    J Pharm Sci; 2016 Feb; 105(2):797-807. PubMed ID: 26869430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery.
    Deli MA
    Biochim Biophys Acta; 2009 Apr; 1788(4):892-910. PubMed ID: 18983815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
    Tam VH; Sosa C; Liu R; Yao N; Priestley RD
    Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypeptide delivery across the blood-brain barrier.
    Pan W; Kastin AJ
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):131-6. PubMed ID: 15078188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of peptide and protein drugs over the blood-brain barrier.
    Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
    Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brain.
    Sarkar G; Curran GL; Sarkaria JN; Lowe VJ; Jenkins RB
    PLoS One; 2014; 9(5):e97655. PubMed ID: 24847943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
    Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
    Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strategies for drug delivery to the brain across the blood-brain barrier].
    Tsuji A
    Nihon Rinsho; 1998 Mar; 56(3):613-8. PubMed ID: 9549345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically synthesized peptide libraries as a new source of BBB shuttles. Use of mass spectrometry for peptide identification.
    Guixer B; Arroyo X; Belda I; Sabidó E; Teixidó M; Giralt E
    J Pept Sci; 2016 Sep; 22(9):577-91. PubMed ID: 27440580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.